FDA hastily approves Daiichi Sankyo/AZ’s cancer drug, weeks after US filing

FDA hastily approves Daiichi Sankyo/AZ’s cancer drug, weeks after US filing

Source: 
Pharmaforum
snippet: 

The FDA has approved an advanced breast cancer drug from AstraZeneca and Daiichi Sankyo in super-quick time.